StockNews.com started coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a research note issued to investors on Thursday morning. The firm issued a sell rating on the stock. Navidea Biopharmaceuticals Trading Down 99.7 % NYSE NAVB opened at $0.00 on Thursday. The company has a 50 day moving average of $0.04 and […]
StockNews.com assumed coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a research note issued to investors on Thursday. The brokerage issued a sell rating on the stock. Navidea Biopharmaceuticals Stock Performance Shares of NAVB opened at $0.00 on Thursday. Navidea Biopharmaceuticals has a fifty-two week low of $0.00 and a fifty-two week […]
StockNews.com initiated coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a research note released on Thursday. The brokerage issued a sell rating on the stock. Navidea Biopharmaceuticals Stock Performance Navidea Biopharmaceuticals has a twelve month low of $0.00 and a twelve month high of $0.17. The stock’s fifty day moving average price […]
The significant growth in the ambulatory surgical centers market can be credited to several factors highlighting the rising need for multispecialty outpatient surgical facilities. A primary
/PRNewswire/ DelveInsight s Infection Prevention and Control Market Insights report provides the current and forecast market analysis, individual leading.